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Closmetics are deJtned as an article intended to be applied to the ltuman body for cleansing,
beautifying, promoting attractiveiless, or abering the appearance without aflbcting the body's
structure or function. Cosmetics are asserted not to have any therapeutic e/fects. Cosmecetttical is
refer to a casmetic product whase active ingr edient is meant to have a heneficial physioktgic e.ffbct
resulting from an enhanced pharmacologic oction when compared with an inert cosmetic and
generally used to refbr to skin care prodttcts thai are henelicial to imprafing skin's atrtpearanc:e and
promrsting healthy skin. Cosmeceuticals contain ingredients that inJluence the biological 
.function of
the skin and improve appearance by delivering nutrients ilece,\sary 
.for healthy skin. There are
problematic skin conditions that might change the interactive psttern and outcome betv,een
cosmeceuticals and skin. Ph.vsicians must.fully evaluate a patient's skin type, assess lhe degree ef
photodamage and take into account an1, pre-existing skin condilions in order to design an
ctppropriate regitnen. The success of both cosmetic and pharmacetttical prodttcts depends on an
appropriate integration af'skin struclure and function aspects with the nature of the formulation
(cosmeceuticals), its efiicaq,as defined b),the goal of the product (costnetic or cosmeceuticall and its
saJbty.
INTRODUCTION
Skin is a dynamic organ, meaning that it is always in a state of flux. Skin cells are
constantly being exfoliated and replenished and will be replaced by new skin cells. Most of
people have some flarvs in their complexion which are troublesome to the, whether it be acne,
rosacea, or related issues, fine lines and wrinkles, age spots, broken capillaries, facial
discoloration including melasma, and dry/oily or scaly skin. Other concems may inciude
tone. texture and loss of volume as well.
A combination of therapy' and procedures is almost always necessary to obtain a
satisfactory result. There are some intrinsic factors that can be aggravated or accelerated by
extrinsic factors including improper or inadequate skin care, exsessive sunlight exposure
including artificial tanning. and smoking among other factors.
There are some of common conditions of skin problern that often occur in cosmetic
dermatology field such as acne, rosacea, wrinkles, traumatic scars, age spots, melasma.
textural problems including dry spots. sun damage. rough and dry skin, and facial redness.
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Those conditions listed as many options available to address the issue. Tt is expected that
multiple products and treatment rnodalities and combinations thereof will need to be used to
obtain improvement but none of the treatment stop aging and a maintenance program is
necessary to insure continued healthier and more beautiful skin.
In previous decades, skin conditions, such as male-pattern baldness, dandrufl, skin
aging. and wrinkles, wsre managed using cosmetics. In general, c'o,sntetics are asserted not to
have any therapeutic effects and have been defined by the U.S. Federal Food, Drug, alrd
Cosmetic Act (FD&C) as'oan article intended to be applied to the human body for cleansing.
beautifying, promoting attractiveness, or altering the appearance without aft'ecting the body's
structure or function." In contrast, a drug is defined by FD&C as 'oan article intended for use
in the diagnosis, cure, mitigation. treatment or prevention of disease, (or) intended to affect
the structure or any function ofthe body."
Cosnretics are "articles intended to be rubbed, poured, sprinkled, or sprayed on,
introduced into, or otherwise applied to the human body or any part there of for cleansing,
beautifying, promoting attractiveness. or altering the appearance and articles intended for use
as a component of any such article. except that such term shall not include soap."
Cosmeceuticals are a new breed of skin care products that are a hybrid between
cosmetics and pharmaceuticals. The term "cosmeceutical" was coined in l96l by Raymond
Reed, founding member of the U.S. Society"of Cosmetic Chemists. He originally conceived
the word to describe "active" and science-based cosmetics.
The rvord and concept were further popularized by Dr Albert Kligman in the late
1970s. with the development of prescription-strength tretinr:in for the enhanced appearance of
ultraviolet (tJV) damaged and wrinkled skin. A cosmeceutical is a cosmetic product whose
active ingredient is meant to have a beneficial physiologic effect resulting from an enhanced
pharmacologic action r.vhen compared with an inert cosmetic.
The term cosmeceutical is not recognized by the Food and Drug Administration so
there are no specific criteria set up for products to be included in this category. This term is
engrained in medical literature, the lay press. and is commonly used by consumers. There is
an itnplied medical nature as a result of "ceutical" and an expectation of medicinal-like
properties. Today' cosmeceutical is generally used to refbr to skin care products that contain
active ingredients that are beneficial to improving skin's appearance and promoting healthy
skin.
Common usage has expanded the definition to include "a cosmetic that has or is
purported to have medicinal properties." The cosmetic industry uses the term to indicate
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those products that atfect the health of skin or that have a sustained effect on the skin's
appearance beyond the time of application. These definitions imply a phl,siologic or
pharmacologic action. With the exception of tretinoin and tazarotene the products in this class
are sold over-the-counter (OTC) and are regulated as cosmetics, not pharmaceuticals.
Physicians practicing aesthetic medicine have also played a role in expanding the use
of cosmeceuticals. Cosmeceuticals are now a regular part of our treatrnent armamentarium
and are used in addition to rnedications and procedures to improve patient outcomes. Anti-
aging cosmeceuticals are among the most frequently recommended by physicians who utilize
them as an integral part of a comprehensive skin rejuvenation program. Moisturizers and
serums containing ingredients like vitamin C. niacinamide, retinol, peptides, grorvth factors
and botanicals can all be used in this regard.
In addition, patients undergoing cosmetic procedures such as laser resurfacing and
chemical peels may be given cosmeceuticals to "prime" the skin for procedures, encourage
healing and reduce complications after. Cosmeceuticals are also recommended for patients
with acne, rosacea, eczema and other skin conditions where they are commonly used in
combination with prescription medications. For example, moisturizers containing anti-
inflammatory botanical ingredients may be used in conjunction with prescription medications
fbr treating rosacea. Cosmeceuticals containing soy can be used to provide added skin
lightening beneflts when paired r.vith hydroquinone. This shift in treatment paradigms has
placed the use of cosmeceuticals within the purview of medicalpractice.
It takes time and skill to develop individualized skin care regimens for patients.
Physicians must l'ully evaluate a patient's skin type, assess the degree of photodamage and
take into accounl any pre-existing skin conditions in order to design an appropriate regimen.
lt is important to consider if the patienl has oily, dry or sensitive skin or if there are any
preexisting skin conditions like set'rorrhea, eczema, acnei and rosacea. Lifestyle
considerations such as hobbies, sporting activities and occupation also play a role.
A basic skin care regimen required to maintain skin health and beauty is made up of a
cleanser, moisturizer and sunscreen. Toners, astringents and eye creams may aiso be included
although these products are not considered essential. In general, regimens for cosmetic
patients should include daltime products that protect the skin and nighttime products that will
repair skin damage.
Skin type classification is a good starting point" with dry" oily, normal, or conrbination
of dry and oily, as common types. Complex mechanisms influence the skin type, such as
gender, age. hormonal status, and ethnic background. Skin changes over time and elderly
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people quite often experience very dry skin conditions. Similarly, honnonal changes,
pa$icularly in women during different stages of litb, such as menopause, need to be taken
into account. Etl-uric background is also important, as different skin phototypes shorv varying
sensitivity to UV light, resulting in different degrees of sunburn, tanning or photoaging,
rvhich can thus indirectly impact the etficacy of active ingredients. Finaily. climate
(lemperature, humidity, seasonal changes). food and lifestyle have a profound. long-term
inf'luence on the skin.
Cosmeceuticals are intended to carryr out their functions as protection, whitening,
tanning. antiwrinkling, deodorants, antiaging, and nail and hair care. Cosmeceuticals mav"
however, cause some un*'anted problems. The common ones are iritability to the skin,
contact dermatitis, photosensitivity, comedogenicity, hair and nail darnage, hyper- or
hypopigrnentation, infectivity, carcinogenicity, and even systemic adverse effects.
The research and development of cosmeceuticals, especially the composite active
ingredients, should be based on their clarified sourees, structures, interactive mechanisms
with the skin, and, most importantly, their eflicacy and safety on the targeted components of
skin. Here we review some of the cosmeceuticals with different categories of functions, with
special focuses on their biologically active ingredients.
Clearly, to claim that a product is a cosmeceutical, it has to fuIfilI three important
conditions:
1. It has to include scientifically proven active ingredients at concentrations that have
physiological effects and make observable improvements of human skin. The effects
would be reduction of fine lines and wrinkles, thickening of the epidermis, increased,
normal collagen network, improved elastin deposition, restoration of natural
moisturizing factors, normalization of skin color and removal of pigmentation
blemishes, or normalization of sebum secretion.
2. A cosmeceutical should be formulated to give optimum penetration of the active
ingredients. A product with adequate concentrations of effective ingredients will not
work as a cosmeceutical if the formula does not ensure good penetration of those
ingredients into the area where they are needed. In some cases, transdermal
penetration has to be enhanced to position the active molecule where it is most
needed.
3. A cosmeceutical should not expose the client to any deleterious consequences,
although one has to realize that because effective concentrations of active ingredients
are used, the possibility of transient skin reactions does increase. This is in keeping
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with the Gauss distribution curye. [nevitably, some people may develop skin
irritation, whereas most get good changes or even superb changes to their skin. For
that reason, cosmeceuticals should only be administered by trained skin care
therapists who can advise clients on the proper way to use them, and ideally
cosmeceuticals should not be sold over-the-counter in department stores and others.
Cosmeceutical ingredients should be classified as follows:
- Those that are naturally found in the skin (e.g., chirally correct vitamins)
- Phytonutrients not normally tbund in skin but have physiological benefits (e.g".
green tea polyphenols)
- Designed molecules (e.g., peptides not normally found in nature but that have
physiologicalactions due to their cytokine actiyity)
The success of both cosmetic and pharmaceuticai products depends on an appropriate
integration of skin structure and llnction aspects with the nature of the formulation
(pharmaceuticals), its efficacy as defined by the goal of the product (cosmetic or
pharmaceutical), and its safbty.
Like cosmetics. cosmeceuticals are topically applied, but they contain ingredients that
influence the biological function of the skin. Cosmeceuticals improve appearance by
delivering nutrients necessary for healthy skin. Cosmeceuticals typically clairn to improve
skin tone, texture. and radiance, while reducing wrinkling. Cosmeceuticals are the
fastest-growing segment of the natural personal care industry. Commonly used substances
included in cosmeceutical formulations are described as follows:
Moisturizing Agents
Stratum corneum is the primary barrier of the skin whose one of main purpose is to
keep inside in & outside out. This bamier is rich in cholesterol, free fatty acids. and
ceramides. Many oily preparations have been used to maintain the fluidity of the skin
(Mineral oil, Lanolin. cyclomethicone, etc.). Water from the stratum corneum gets evaporated
very quickly leading to dehydration. This dehydration of skin can be averted by using
moisturizers which provide flexibility to the skin.
Humectants are cardinal ingredients of the moisturizing formulations. Humectants
also help in preventing drying out of the formulations. When moisturizers are applied to the
skin, a thin film of humectant is formed which retains moisture and imparts better appearance
to the skin. Bio-mimetic lipid containing fbrmulations facilitate in normalizing the damaged
skin. Water can cause the excretion of cyokines when applied to the skin for a prolonged
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period of' time. This may further lead to edema, vasodilatation, and inflammation gets
induced.
Moisturizers by hydrating the skin, make the stratum corneum softer & can even alter
physiology of skin. Ceramide containing moisturizers are very popular as these contain the
same balance of lipids as our skin. There are nine diflerent types of ceramides in the stratum
corneum named as ceramide. They constitute 40-5A% of the lipids in this outermost layer. It
has been proven that these substances help to treat eczema, and can even be used for dry skin.
Fluocinolide containing ceramides formulation has been found to reduce eczema.
Besides these, black cohosh. soy extract, and vitamins A and E also help in augmenting the
skin's natural moisture balance. Complex mixture of hyaluronic acid and a revival complex
containing green tea leaf extract, and glutathione are also promising moisturising agents.
Sunscreen Agents
Use of sunscreen agents and limiting the exposure to sun prevents early wrinkling and
skin cancer. Sunscreen agents are used to prevent sunbums. There are two kinds of sunscreen
agents: chemical and physical. Chemical sunscreen agents protect the skin from the sun by
absorbing the ultraviolet (UV) and visible sun rays. while physical sunscreen agents reflect,
scatter, absorb, or block the rays.
Sunscreen agents often may comprise more than one ingredient. For example,
products may contain an ingredient that provides protection against the ultraviolet A (UVA)
sun rays and another ingredient that protects from the ultraviolet B (UVB) sun rays, which
are more likely to cause sunburns than the UVA sun rays. Ideally, coverage should include
protection against both UVA and UVB sun rays.
The sun protection factor (SPF) that is present on the label ofthese products reflects
the minimum amount of UVB suniight that is needed with that prodlrct to produce redness on
sunscreen protected skin as compared with unprotected skin. Sunscreen products with high
SPFs provide more protection against the sun. The following sunscreen agents have been
recommended by the U.S. Department of Health :
. Cycloform (isobutyl p-amino benzoate)
. Propylene glycol p-amino benzoate
. IUonoglyceryl p-amino benzoate
. Digalloyl trioleate
. Benzyl salicylate and benzyl cinnamate (2%o each)
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Besides these, chemical sunscreens mainly based on para-amino benzoic acid, its
deivatives, cinnamates, various salicylates and benzophenones, dibenzoylmethanes,
anthraline derivatives, octocrylene and homosalate are frequently employed as sun blocking
agents. Direct physical blockers include metal containing compounds such as iron, zinc,
titanium, and bismuth.
Zinc oxide and titanium dioxide are highly reflective w'hite powders, but submicron
zinc oxide or titaniumdioxide powder particles transmit visible light while retaining their UV
blocking properties. thus rendering the sun block invisible on the skin. Other commercially
available sunscreens are Benzophenone-8, Neo Heliopan MA and BB, Parsol MCX and HS,
Escalol 557,587, and 59740.
Hydroxy Acids
Hydroxy acids are organic carboxylic acids classified into alpha-hydroxy acids
(AHA), beta-hydroxy acids (BHA), poly-hydroxy acids. and bionic acids on the basis of their
molecular structure. Hydroxy acids are found in most of the marketed cosmetic preparation
but are used in very low concentration. Alpha-hydroxy acids range from simple aliphatic
compounds to complex molecules.
Derived product can be either from natural or non-natural origin, product derived
from natural origin are krown as fruit acid. Hydroxy acids are tbund to be present in
antiaging formulations, moisturizers, and peels, and in treatment products to improve
hyperpigmentation and acne. The skin appears to be smoother and more uniform. The likely
cause of these changes is the properfy of AHAs to enhance epidermal shedding. Some claim
that AHAs increase the synthesis of glycosaminoglycans (CACs), improve the quality of
elastic fibers, and increase the density of collagen.
Beta-hydroxy acids are aromatic compounds. Salicylic acid is the reference BHA; it
has dennatoly'tic propemies and helps in various xerotic and ichthyotic disorders. Other BHAs
include 2-hydroxy-5-octanoyl benzoic acid, also known as beta-lipo-hydroxyacid (B-LHA),
and tropic acid.
Mechanism of action of hydroxyl acid is unknown however one finding of its
biological activities may be attributed to the inherent acid strength of the compounds. Ability
of AHAs to increase sensitivity to UV radiation has been proved and thus sunscreen
application may be advisable when these products are used. Some AHAs comprise the
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following: lactobionic acid, gl,vcolic acid, lactic acid, citric acid, mandelic acid, malic acid,
and tartaric acid.
Vitamins
Exposure to the UV radiations accelerates the aging effect of the skin. The
progressive telomere shortening and finally its disruption by low-grade oxidative damage are
related to the aging. Damage is initiated by the generation of reactive oxygen species (tiee
radicals). It is a progressive process whose consequences are damage to DNA.
The topical treatment of acne vulgaris with vitamin A. is very well supported by
evidence. Vitamin 83, commonly known as nicotinamide or niacinamide, is available in
cosmetic and cosmeceutical products and can be used as a complementary agent for some
types of acne, as well as aging skin.
Activation of toll-like receptors may also be involved in the scarring process by
activating the metalloproteinases. The retinoids are vitamin A derivatives constituting the
most effective comedolyic agents. They function by normalizing desquamation of the
follicular epithelium, preventing the formation of new microcomedo, and minimizing the
formation of comedones and inflammatory lesions.
Nicotinamide is useful as a complementary dnrg because of its mild
anti-inflammatory activity and its possible action in the reduction of sebum production and
improvement of the skin barrier.
Vitamin A
The human epidermis contains significant amounts of vitamin A (all-trans-retinol). It
has been observed that both UVB and UVA can damage the metabolism and hansport of
vitamin A. This may lead to vitamin A deficiency in the skin. Small amounts of retinol in the
body gets converted to all-trans retinoic acid also called tretinoin (active form) and rest of the
retinol is convefted into retinyl ester (storage form).
Topical rctinoids have successfully been used to treat acne. The efficacy of topical
tretinoin in the treatment of photoaged and intrinsically aged skin is sufficiently established.
The effects are believed to be mediated through its binding to the nuclear retinoid acid
receptors. It induces type I and type III pro-collagen gene expression in human skin, resulting
in increased deposition of collagen fibrils in the dermis. The effects result in an improvement
in the clinical and histologic skin appearance.
8
Tretinoin cream in the appropriated concentrations of 0.025yq 0.05%. and 0.lYo. as
well as 0.1% isotretinoin and 0.lYo tazarotene, frequently produce moderate to severe skin
imitation. Retinaldehyde (0.05%) is another useful topical agent for the treatment of
photoaged skin. It has a lower frequency of irritation but less efficacy than tretinoin.
Photosenstivity is another problem to be dealt in case of tretinoin. The useful
concentration of topical retinol ranges from 0.3% to lYo. Most of the over-the'counter
products available usually contain lower levels of retinol (about 0.08% or less), compared
with the concentration used in the few clinical studies available.
Vitamin A exists in three isomeric forms among which beta form found to be more
active than alpha & gamma isomer. Its deflciency may lead to dry rough skin. The advent of
synthetic analogs of vitamin A in the 1970s brought new interest into their biological activity,
especially on the skin. Since then, vitamin A and its derivatives haye been useful in the
treatment of many skin disorders, including ichthyosis, acne, and psoriasis. A great amount of
research has concentrated on its use as an antiaging compound as well as its use for other
cutaneous disorders.
As antioxidants, vitamin A protects cells from oxidative damage by 3 different
mechanisms: scavenging peroxyl radicals, quenching singlet oxygen, and triplet-state
sensitizers. Vitamin A and its derivatives have 2 main functions: they act as antioxidants, and
they activate specific genes and proteins. Vitamin A also exerts a homone like effect on the
skin, activating specific genes through nuclear receptors.
Vitamin E
The physiological function of vitamin E, if applied dermally is to contribute to the
antioxidant defense of the skin, because of its tendency to absorb W light in the solar
spectrum region that is responsible for most of the harmful biologic effects of the sun.
Vitamin E blocks lipid peroxidation in cells & tissues & it is a good antioxidant. It helps to
enhance the performance of IJV filters, softens skin & moisturizes within.
Vitamin E, is the body's major lipid-soluble antioxidant, if oxidized, vitamin E can be
regenerated back to its reduced form by L-ascorbic acid. Vitamin E as alpha-tocopherol or
tocopherol acetate is used in topical OTC (over-the counter) products in concentration (l% -
5%). Alpha-tocopherol has been found to be beneficial in reducing minimal erl,thema and the
number of epidermal sunburn cells, which marks skin damage related to oxidative stress
caused by UVB.
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T'he effect of vitamin E after sun exposure seems to have no benefit. Vitamin E can
reduce UV-induced ery4hema and edema when it is applied before UV exposure. Topical
application of vitamin E may'increase stratum corneum hydration antl enhance water-binding
capacity. Alpha-tocopherol also shows synergistic effbct with vitarnins A (retinol) and C
(ascorbic acid) in combined products, providing an appreciable photo protection and
antioxidant action that suggests a potential effect in the protection against photo aging and
skin cancer.
Vitamin 83 (niacinamide or nicotinamide)
Nicotinamide is a part of'the coenzymes nicotinamide adenine dinucleotide (NAD),
NAD phosphate (1\{ADP). and its reduced forms are NADH and NADpH. These molecules
are important in many cellular rnetabolic enzyme reactions. The reduced forms nrainly act as
antioxidants.
Nicotinamide is one of the newly discovered vitamin-based components of
cosmeceutical products' lt is found to possess antiinflammatory and anti acne actions. lts
anti-inflammatory effect may improve skin appearance by reducing leucocyte peroxidase
systems that may lead to localized tissue damage as r.vell as improve the stratum corneum
barrier. In a study, the anti-inflammatory effect of 4%o nicotinamide gel in the treatment of
acne vulgaris was comparable as the benefits of lYo clindamycin gel. This effect also shows
significance to reduce cutaneous erl,thema in various disorders.
The amelioration of facial depigmentation is mediated by the suppression of
melanosome transfer from melanocltes to keratinocytes. In fibroblast culture nicotinamide
increases collagen production and this effect may lead for the improvement of skin elasticity
and reduction of fine wrinkles.
Vitamin C
The increase of vitamin C in skin concentration is limited even with huge oral
supplementation. Vitamin C has become a popular topically applied cosmeceutical because
topical application of L-ascorbic acid is the only way to further increase skin concentration.
Free radical scavengers have grabbed the attention of researchers on vitamin C.
L-ascorbic acid is the active form of vitamin-C, which was first used as cosmeceutical
creams- Despite these controversies, all the researchers agree that topically applied vitamin C
has many benefits, such as lightening hyperpigmentation, promoting collagen synthesis.
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antiinflammatory and photoprotective properties. Vitamin C and its derivatives are believed
to shor,v reducing efl-ects on melanin intermediates. They inhibit the oxidative chain reaction
from fyrosine/dihydroxyphenylalanine (DOPA) to melanin. It is required for the
hydroxylation of procollagen, proline, and lysine. Its deflciency can cause keratotic follicles,
purpura and bleeding gums [t is an important regulator of collagen expression stimulating its
synthesis, a water-soluble antioxidant that clenches free radicals and regenerates vitamin E.
Vitamin C levels on the skin are severely depleted after tiV irradiation and it
improves and normalizes the changes caused by light damage.
Skin Lightening Agents
Hyperpigmentation is the changing of colour intensity of the skin to darker hue, which
is due to an increased amount of melanin in the epidermis, the dermis, or both. This change
can be due to 2 pathophysiologic processes: melanocytosis (increased number of
melanocl,tes) and melanosis (increased amount of melanin).
Skin lightening agents work best when melanosis or melanocytosis is confined to the
epidermis. Patients with Fitzpatrick skin types I-I1l have advantage over type IV such as type
I-III benefit from local pigment lightening for the treatment of hormonally induced melasma
and postinflammatory hyperpigmentation caused by acne and trauma, whereas those with
Fitzpatrick skin types IV and darker may also seek therapy for pigmentary changes that occur
around the eyes, in the intertriginous areas, following dermatitis. or with acne and trauma.
Standard dermatologic agent for skin lightening is hydroquinone but its safety is
questionable, leading to the use of alternative agents such as retinoids, mequinol, azelaic acid,
arbutin, kojic acid, aleosin, Iicorice extract, ascorbic acid, soy proteins, and N -acetyl
glucosamine.
Chemical Peeling Agents
Alpha-hydroxy acids have been shown to lighten melasma, solar lentigines, and
post-inflammatory hyper pigmentation. Glycolic acid is derived from sugar cane and is used
as an ingredient in skinlightening products in low concentrations. It may also be used as a
peeling agent in concentrations of 30-70%o to increase the efficacy of other lightening agents
such as hydroquinone by removal of the dead skin, thus enhancing the penetration of
hydroquinone.
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Repeated peels every 2-3 weeks are necessary to attain significant lightening. Other
chemical peels include 50Yo trichloroacetic acid (TCA) peels and 2A4A% salicylic acid peels
used for various pigmentary disorders, including melasma, on darker skin types.
Conclusion
The interactions betrveen cosmeceuticals and skin are complex, depending on the specific
composites in cosmeceuticals products, condition of the skin or general health status of a
subject, and also the environment where the action occurs. Hundreds of substances have been
screened, synthesized. and tested and many have been included in comrnercially available
products. In addition, the desired functions of a cosmeceuticais might require a coordinating
action of multiple ingredients. Moreover, there are problematic skin conditions that might
change the interactive pattem and outcome between cosmeceuticals and skin, Cosmeceuticals
like vitamins, sunscreens, hydroxy acids & many more have proved their etficacy in treating
skin diseases thus enhancing the skin texture. Clinical trials of cosmeceuticals are important
to know the interaction between skin and cosmeceuticals which could even be influenced by
environmental fact. Scientific clinical evaluation is a must fbr research, development, and
application of cosmeceuticals.
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